Johns Hopkins Kimmel Cancer Center Director Dr. Bill Nelson talks to Dr. Elana Fertig about how she is using genomic research, mathematical modeling, chaos theory and her past experience in weather prediction to develop treatments for cancer in our latest podcast.
Cancer Matters with Dr. Bill Nelson – Cancer and the Immune System
Posted by | podcastKimmel Cancer Center Director Dr. Bill Nelson talks with Dr. Mark Yarchoan and Alex Hopkins about how cancer cells evade the immune system and what researchers are doing to combat that with targeted immunotherapies.
Cancer Matters with Dr. Bill Nelson – Cell Biology With Dr. Andrew Ewald
Posted by | podcastDr Bill Nelson and biologist Andrew Ewald discuss the new ways that scientists are confronting the cancer on the cellular level and using physics to study how cancer cells spread to new areas. Dr Ewald was recently featured in a piece from The Hub at JHU. You can read that here.
Kimmel In DC With Dr. Ben Levy – Advanced Practice Provider Rasheda Persinger
Posted by | podcastDr. Ben Levy, the Director of Medical Oncology at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital in Washington DC, begins his podcast series talking with Rasheda Persinger, and Nurse Practitioner at Sibley. They discuss the key role of Advanced Practice Providers in delivering care to cancer patients and helping them navigate the(...)
Cancer Matters with Dr. Bill Nelson – Proton Therapy with Dr. Ted DeWeese
Posted by | podcastKimmel Cancer Center Director Dr Bill Nelson talks to Dr Ted DeWeese, the Center’s Director of the Department of Radiation Oncology and Molecular Radiation Sciences, about the advances in radiation therapy and how treatments are becoming more refined and targeted. In the Fall of 2019 at proton therapy center that will come online at Sibley(...)
Cancer Matters with Dr Bill Nelson – New AACR President Dr Elizabeth Jaffee
Posted by | podcastDr Bill Nelson, the Director of the Kimmel Cancer Center at Johns Hopkins, begins a new podcast series focused on cancer treatment and research. In episode one, Dr Nelson speaks with Dr Elizabeth Jaffee, the Kimmel Cancer Center’s Deputy Director and the Associate Director of the Bloomberg~Kimmel Institute for Cancer Immunotherapy, from the annual meeting(...)
Welcome to the Skip Viragh Outpatient Cancer Building
Posted by | UncategorizedOn May 15, 2018, Skip Viragh’s vision for a single place where cancer patients can receive top-notch outpatient cancer care was realized with the opening of the Skip Viragh Outpatient Cancer Building at the Johns Hopkins Kimmel Cancer Center. Our new hub for cancer services and clinical research provides one-stop for stellar cancer diagnostic and(...)
A Look Inside the Kimmel Cancer Center’s Cancer Medicine Cabinet
Posted by | Issues & Perspectives, Patient Stories, Prevention/Screening, Research, treatmentRead the latest issue of Promise & Progress featuring research advances in cancer drug discovery and development, promising new cancer drugs, patient stories and more. From scientific meetings to our own dinner tables, conversations about better treatments for cancer are among the most frequently discussed health care topics. Everyone wants them—the doctors and scientists who(...)
Starting a Conversation about Advance Directives
Posted by | caregivingBright and early at 6 am on April 16th, Harry J. Duffey Family Patient and Family Services staff members greeted patients clad in t-shirts encouraging them to learn about advance directives. The effort was part of the National Healthcare Decisions Day “Start a Conversation Project” and is aimed at helping people understand advance directives and(...)
Jaffee to Lead AACR; Conference Focuses on Innovative Cancer Science
Posted by | ResearchDriving innovative cancer science to patient care is the theme for this year’s American Association for Cancer Research annual meeting in Chicago. As more progress against cancer emerges from various areas of study, scientists are bringing different tools and skills together to help diagnose cancer at an earlier stage, increasing the chances of effective treatment(...)